Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-06-08
1996-12-24
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
055873979
ABSTRACT:
This invention discloses an improved method of reducing elevated lactic acid and lactate concentrations in patients suffering from ischemic or hypoxic crises as stroke, cardiac arrest, or heart attacks, or other conditions involving surgery, that generate unwanted increases in blood or tissue lactate concentrations. This improvement comprises administering dichloroacetate (DCA), as in the sodium salt form, less than three times daily, at suitable dosages which cause the beneficial effects of DCA to persist beyond the time when the DCA has been pharmacokinetically cleared from the blood circulating in the patient.
REFERENCES:
patent: 4122188 (1978-10-01), Stacpoole
patent: 4631294 (1986-12-01), Barsan
Crabbe, D. W., et al, "The metabolic effects of dichloroacetate," Metabolism 30: 1024-1039 (1981).
Evans, O. B., "Dichloroacetate tissue concentrations and its relationship to hypolactatemia and pyruvate dehydrogenase activation," Biochem Pharmacol 31:3124-3126 (1982).
Lukas, G., et al, "Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration," J Pharmaceut Sci 69: 419-421 (1980).
Ribes, G., et al, "Metabolic effects of sodium dichloroacetate," Diabetes 28: 852-856 (1979).
Stacpoole, P. W., et al, "Toxicity of chronic dichloroacetate," New Eng J Med 300: 372 (1979).
Stacpoole, P.W., et al, "Dichloroacetate in the treatment of lactic acidosis," Ann. Internal Med 108: 58-63 (1988).
Stacpoole, P. W., "The pharmacology of dichloroacetate," Metabolism 38: 1124-1144 (1989).
Wells, P. G., et al, "Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans," Diabetologica 19: 109-113 (1980).
Cypros Pharmaceutical Corporation
Kelly Patrick D.
Spivack Phyllis G.
LandOfFree
Reduction of elevated blood lactate using twice-daily dichloroac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduction of elevated blood lactate using twice-daily dichloroac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of elevated blood lactate using twice-daily dichloroac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178848